Clinical utility of PET/CT in lymphoma

Carmel G. Cronin, Ronan Swords, Mylene T. Truong, Chitra Viswanathan, Eric Rohren, Francis J. Giles, Michael O'Dwyer, John F. Bruzzi

Research output: Contribution to journalReview articlepeer-review

108 Scopus citations


OBJECTIVE. The purpose of this review is to assist interpreting radiologists in becoming familiar with the role of PET/CT in baseline staging and therapeutic response assessment in the management of lymphoma, in becoming aware of imaging pitfalls, and in understanding the natural behavior of lymphoma and the therapeutic options. CONCLUSION. Therapeutic strategies for the management of lymphoma are constantly being refined to improve long-term survival with the lowest risk of toxicity to the patient. PET/CT is accurate for baseline staging and yields important prognostic information for determining the most appropriate initial treatment. Used for evaluation of treatment response, PET/CT can depict residual viable malignant lesions with greater accuracy than can other imaging techniques. The findings thereby influence decisions about the need for additional or alternative treatment.

Original languageEnglish (US)
Pages (from-to)W91-W103
JournalAmerican Journal of Roentgenology
Issue number1
StatePublished - Jan 2010


  • Lymphoma
  • PET/CT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Clinical utility of PET/CT in lymphoma'. Together they form a unique fingerprint.

Cite this